In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

EHS publications on Diabetes and the Heart

Check all results from our studies on Diabetes and Cardiovascular Diseases

Diabetes and the Heart


Results are published in the European Heart Journal

  • The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. Bartnik  M, Rydén L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, Standl E, Soler-Soler J, Öhrvik J, on behalf of the Euro Heart Survey Investigators. Eur Heart J 2004;25:1880-90.
  • M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L . Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004;25:1990-7.
  • Dotevall A, Rosengren A, Bartnik M, Malmberg K, Öhrvik J, Simoons M, Rydén L. Sex-related aspects on abnormal glucose regulation in patients with coronary artery disease. Eur Heart J. 2007; 28: 310 – 315.


Other Journals

  • Lenzen M, Rydén L, Öhrvik J, Bartnik M, Malmberg K, Scholte op Reime W, Simmons M L. Diabetes known or newly detected, but not impaired glucose regulation has a negative influence on 1-years outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Europ Heart J 2006; 27:2969-2974.
  • Bartnik M, Rydén L, Malmberg K, Öhrvik J, Pyörälä K, Standl E, Ferrari R, Simoons M, Soler-Soler J. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease. A report from the Euro Heart Survey on diabetes and the heart. Heart 2007; 93:72-77.  
  • Anselmino M, Bartnik M, Malmberg K, Rydén L on behalf of the Euro Heart Survey Investigators. Management of coronary artery disease in patients with and without diabetes mellitus. Acute management reasonable but secondary prevention unacceptably poor: a report from the Euro Heart Survey on Diabetes and the heart. Eur J Cardiovasc Prev Rehab 2007; 14: 28-36.
  • Anselmino M, Malmberg K, Öhrvik J, Rydén L on behalf of the Euro Heart survey Investigators. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease. A report from the Euro Heart Survey on Diabetes and the Heart. Eur J Cardiovasc Prev Rehabil. 2008;15:216-223.
  • Anselmino M, Öhrvik J, Malmberg K, Standl E, Rydén L on behalf of the Euro Heart Survey Investigators.  Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart. Europ Heart J. 2008; 29:177-184.